-- U.S. patients with Type 2 diabetes can now access diabetic medications such as Rybelsus (Semaglutide) through Better You Rx at a price of $294.79. The Canada-based prescription referral service provides treatment access to American diabetes patients who are financially struggling to afford diabetes care.
What To Know About Rybelsus
Rybelsus is the first oral GLP-1 receptor agonist. This diabetic medication makes diabetes care easier and more convenient. It contains Semaglutide, mimicking the body’s hormones to regulate blood sugar. Taking Rybelsus can maintain blood sugar levels and improve glycemic control.
It is offered in three dosage options such as 3 mg, 7 mg, and 14 mg. It is recommendable to reach out to professional healthcare providers to consult on the appropriate treatment plan, including recommended dosage regulation.
Understanding How To Utilize and Store Rybelsus
Rybelsus (Semaglutide) is only advisable to be taken once a day orally. It should be taken with an empty stomach, approximately 30 minutes before the first meal or drink to ensure optimal absorption and effectiveness.
Diabetes treatment plans differ from patient to patient. It is recommended to consult a healthcare provider for the recommended dosage and usage frequency.
The medication should be stored in a cool, dry place. It is advisable to keep the Rybelsus away from sunlight and moisture to retain its effectiveness.
Possible Side Effects from Rybelsus
Determining the dosage that is necessary for the diabetic treatment plan depends from patient to patient. When taking up Rybelsus (Semaglutide), the following side effects and reactions can also be expected:
- Nausea
- Vomiting
- Decreased Appetite
It is recommended to consult a doctor when side effects and reactions persist. For any other inquiries, Better You Rx can also accommodate concerns related to the medication.
The Role of Rybelsus Towards U.S Diabetes Patients
Over 90% out of 38 million US diabetes patients specifically have Type 2 diabetes, resulting in high demands in diabetes medicines. The accessibility of diabetic medicines, such as Rybelsus (Semaglutide), due to lack of supply and high costs lead US patients to ration and skip doses. This inconsistency in the treatment can lead to serious health problems, such as cardiovascular-related risks.
Prescription referral services, such as Better You Rx, source affordable options for diabetes medications in Canada to cater US patients.
Alternative and Affordable Resources for Rybelsus
A 30-day supply of Rybelsus (Semaglutide) usually costs more than $1000 in the U.S., depending on the pharmacy, location, and insurance availability. Sourcing the said medication from Canada is an affordable option, saving up to $700. Better You Rx, a prescription referral service, can source Rybelsus for only $294.79 at trusted pharmacies in Canada.
The said service provider ships affordable diabetic medications from Canada to the U.S. at cost-effective prices.
About Better You Rx
Better You Rx is a Canada-based prescription referral service. It is a trusted pharmacy affiliate that provides cost-efficient options for U.S. patients undergoing diabetes-related treatments. The said service provider ensures hassle-free ordering process with flexible shipping for authentic and high quality alternative medication options from Canada.
Learn more about the services Better You Rx can provide. Visit Betteryourx.com or reach out at 1-647-576-2076 or info@betteryourx.com.
Disclaimer:
This press release is for informational purposes only. Patients are encouraged to consult with their healthcare provider before making any medical decisions. Medications and their prices may change due to regulations and supply issues.
Contact Info:
Name: Anthony Truman
Email: Send Email
Organization: Better You Rx
Address: PO Box 29631, Mississauga RPO Central Parkway, ON L5A 4H2
Phone: 1-647-576-2076
Website: https://betteryourx.com/
Release ID: 89149286
In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
